Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system
2020-01-01 Prelaj, Arsela; Proto, Claudia; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Mensah, Mavis; Galli, Giulia; De Toma, Alessandro; Viscardi, Giuseppe; Brambilla, Marta; Lobefaro, Riccardo; Trevisan, Benedetta; Trovò, Francesco; Torri, Valter; Sozzi, Gabriella; Garassino Marina, Chiara; Boeri, Mattia
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer
2021-01-01 Ferrara, R; Imbimbo, Martina; Malouf, Reem; Paget-Bailly, Sophie; Calais, François; Marchal, Corynne; Westeel, Virginie
Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations
2020-01-01 Ferrara, R; Signorelli, Diego; Proto, Claudia; Prelaj, Arsela; Garassino Marina, Chiara; Lo Russo, Giuseppe
Is hyperprogressive disease a specific phenomenom of immunotherapy?
2020-01-01 Brambilla, Marta; Lo Russo, Giuseppe; Ferrara, R; Manglaviti, Sara; Garassino, Marina; Occhipinti, Mario
Harnessing oncology real-world data with AI
2023-01-01 Mahon, P.; Hall, G.; Dekker, A.; Vehreschild, J.; Tonon, G.
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D
2017-01-01 Simbolo, Michele; Mafficini, Andrea; Sikora Katarzyna, O.; Fassan, Matteo; Barbi, Stefano; Corbo, Vincenzo; Mastracci, Luca; Rusev, Borislav; Grillo, Federica; Vicentini, Caterina; Ferrara, R; Pilotto, Sara; Davini, Federico; Pelosi, Giuseppe; Lawlor Rita, T.; Chilosi, Marco; Tortora, Giampaolo; Bria, Emilio; Fontanini, Gabriella; Volante, Marco; Scarpa, Aldo
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-Reply
2020-01-01 Caramella, Caroline; Ferrara, R; Besse, Benjamin
Tubulin inhibitors in non-small cell lung cancer: looking back and forward
2016-01-01 Ferrara, Roberto; Pilotto, Sara; Peretti, Umberto; Caccese, Mario; Kinspergher, Stefania; Carbognin, Luisa; Karachaliou, N; Rosell, R; Tortora, Giampaolo; Bria, Emilio
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer
2015-01-01 Pilotto, Sara; Novello, Silvia; Peretti, Umberto; Kinspergher, Stefania; Ciuffreda, Ludovica; Milella, Michele; Carbognin, Luisa; Vavalà, Tiziana; Ferrara, Roberto; Caccese, Mario; Tortora, Giampaolo; Bria, Emilio
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
2018-01-01 Ferrara, R; Mezquita, Laura; Texier, Matthieu; Lahmar, Jihene; Audigier-Valette, Clarisse; Tessonnier, Laurent; Mazieres, Julien; Zalcman, Gerard; Brosseau, Solenn; Le Moulec, Sylvestre; Leroy, Laura; Duchemann, Boris; Lefebvre, Corentin; Veillon, Remi; Westeel, Virginie; Koscielny, Serge; Champiat, Stephane; Ferté, Charles; Planchard, David; Remon, Jordi; Boucher, Marie-Eve; Gazzah, Anas; Adam, Julien; Bria, Emilio; Tortora, Giampaolo; Soria, Jean-Charles; Besse, Benjamin; Caramella, Caroline
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies
2021-01-01 A, Russo; L, Incorvaia; E, Capoluongo; P, Tagliaferri; A, Galvano; M Del, Re; U, Malapelle; R, Chiari; P, Conte; R, Danesi; M, Fassan; Ferrara, R; M, Genuardi; P, Ghiorzo; S, Gori; F, Guadagni; A, Marchetti; P, Marchetti; M, Midiri; N, Normanno; F, Passiglia; C, Pinto; N, Silvestris; G, Tallini; S, Vatrano; B, Vincenzi; S, Cinieri; G, Beretta
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
2021-01-01 Fucà, Giovanni; Galli, Giulia; Poggi, Marta; Lo Russo, Giuseppe; Proto, Claudia; Imbimbo, Martina; Ferrara, R; Zilembo, Nicoletta; Ganzinelli, Monica; Sica, Antonio; Torri, Valter; Colombo Mario, Paolo; Vernieri, Claudio; Balsari, Andrea; de Braud, Filippo; Garassino Marina, Chiara; Signorelli, Diego
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study
2018-01-01 Lai W., Victoria; Lebas, Louisiane; Barnes Tristan, A.; Milia, Julie; Ni, Ai; Gautschi, Oliver; Peters, Solange; Ferrara, R; Plodkowski Andrew, J.; Kavanagh, John; Sabari Joshua, K.; Clarke Stephen, J.; Pavlakis, Nick; Drilon, Alexander; Rudin Charles, M.; Arcila Maria, E.; Leighl Natasha, B.; Shepherd Frances, A.; Kris Mark, G.; Mazières, Julien; Li Bob, T.
Pseudoprogression in Non-Small Cell Lung Cancer upon Immunotherapy: Few Drops in the Ocean?
2019-01-01 Ferrara, R; Caramella, Caroline; Besse, Benjamin; Champiat, Stéphane
A Case of William's Syndrome in a Ugandan Child: A Feasible Diagnosis Even in a Low-Resource Setting
2021-01-01 Mapelli, Massimo; Zagni, Paola; Calbi, Valeria; Twalib, Aliku; Ferrara, R; Agostoni, Piergiuseppe
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
2021-01-01 Ferrara, R; Naigeon, Marie; Auclin, Edouard; Duchemann, Boris; Cassard, Lydie; Jouniaux, Jean-Mehdi; Boselli, Lisa; Grivel, Jonathan; Desnoyer, Aude; Mezquita, Laura; Texier, Matthieu; Caramella, Caroline; Hendriks, Lizza; Planchard, David; Remon, Jordi; Sangaletti, Sabina; Proto, Claudia; Garassino Marina, C.; Soria, Jean-Charles; Marabelle, Aurelien; Voisin, Anne-Laure; Farhane, Siham; Besse, Benjamin; Chaput, Nathalie
Facing the First-line in Metastatic Non-small-cell Lung Cancer – Immunotherapy and Chemotherapy
2020-01-01 De Toma, Alessandro; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Prelaj, Arsela; Galli, Giulia; Viscardi, Giuseppe; Trevian, Benedetta; Ganzinelli, Monica; Zilembo, Nicoletta; de Braud, Filippo; Garassino, Marina; Proto, Claudia
Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress?
2020-01-01 Adashek Jacob, J.; Kato, Shumei; Ferrara, R; Lo Russo, Giuseppe; Kurzrock, Razelle
Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors
2019-01-01 Hendriks Lizza, E. L.; Bootsma, Gerben; Mourlanette, Jean; Henon, Clemence; Mezquita, Laura; Ferrara, R; Audigier-Valette, Clarisse; Mazieres, Julien; Lefebvre, Corentin; Duchemann, Boris; Cousin, Sophie; le Pechoux, Cecile; Botticella, Angela; De Ruysscher, Dirk; Dingemans Anne-Marie, C.; Besse, Benjamin
Prognostic value of histogram analysis in advanced non-small cell lung cancer: a radiomic study
2018-01-01 Virginia Bluthgen, Maria; Laura, Faivre; Silvia, Rosellini; Ferrara, R; Francesco, Facchinetti; Eva, Haspinger; Charles, Ferte; Samy, Ammari; Stefan, Michiels; Jean-Charles, Soria; Caroline, Caramella; Benjamin, Besse
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system | 1-gen-2020 | Prelaj, Arsela; Proto, Claudia; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Mensah, Mavis; Galli, Giulia; De Toma, Alessandro; Viscardi, Giuseppe; Brambilla, Marta; Lobefaro, Riccardo; Trevisan, Benedetta; Trovò, Francesco; Torri, Valter; Sozzi, Gabriella; Garassino Marina, Chiara; Boeri, Mattia | |
| Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer | 1-gen-2021 | Ferrara, R; Imbimbo, Martina; Malouf, Reem; Paget-Bailly, Sophie; Calais, François; Marchal, Corynne; Westeel, Virginie | |
| Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations | 1-gen-2020 | Ferrara, R; Signorelli, Diego; Proto, Claudia; Prelaj, Arsela; Garassino Marina, Chiara; Lo Russo, Giuseppe | |
| Is hyperprogressive disease a specific phenomenom of immunotherapy? | 1-gen-2020 | Brambilla, Marta; Lo Russo, Giuseppe; Ferrara, R; Manglaviti, Sara; Garassino, Marina; Occhipinti, Mario | |
| Harnessing oncology real-world data with AI | 1-gen-2023 | Mahon, P.; Hall, G.; Dekker, A.; Vehreschild, J.; Tonon, G. | |
| Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D | 1-gen-2017 | Simbolo, Michele; Mafficini, Andrea; Sikora Katarzyna, O.; Fassan, Matteo; Barbi, Stefano; Corbo, Vincenzo; Mastracci, Luca; Rusev, Borislav; Grillo, Federica; Vicentini, Caterina; Ferrara, R; Pilotto, Sara; Davini, Federico; Pelosi, Giuseppe; Lawlor Rita, T.; Chilosi, Marco; Tortora, Giampaolo; Bria, Emilio; Fontanini, Gabriella; Volante, Marco; Scarpa, Aldo | |
| Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-Reply | 1-gen-2020 | Caramella, Caroline; Ferrara, R; Besse, Benjamin | |
| Tubulin inhibitors in non-small cell lung cancer: looking back and forward | 1-gen-2016 | Ferrara, Roberto; Pilotto, Sara; Peretti, Umberto; Caccese, Mario; Kinspergher, Stefania; Carbognin, Luisa; Karachaliou, N; Rosell, R; Tortora, Giampaolo; Bria, Emilio | |
| An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer | 1-gen-2015 | Pilotto, Sara; Novello, Silvia; Peretti, Umberto; Kinspergher, Stefania; Ciuffreda, Ludovica; Milella, Michele; Carbognin, Luisa; Vavalà, Tiziana; Ferrara, Roberto; Caccese, Mario; Tortora, Giampaolo; Bria, Emilio | |
| Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy | 1-gen-2018 | Ferrara, R; Mezquita, Laura; Texier, Matthieu; Lahmar, Jihene; Audigier-Valette, Clarisse; Tessonnier, Laurent; Mazieres, Julien; Zalcman, Gerard; Brosseau, Solenn; Le Moulec, Sylvestre; Leroy, Laura; Duchemann, Boris; Lefebvre, Corentin; Veillon, Remi; Westeel, Virginie; Koscielny, Serge; Champiat, Stephane; Ferté, Charles; Planchard, David; Remon, Jordi; Boucher, Marie-Eve; Gazzah, Anas; Adam, Julien; Bria, Emilio; Tortora, Giampaolo; Soria, Jean-Charles; Besse, Benjamin; Caramella, Caroline | |
| The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies | 1-gen-2021 | A, Russo; L, Incorvaia; E, Capoluongo; P, Tagliaferri; A, Galvano; M Del, Re; U, Malapelle; R, Chiari; P, Conte; R, Danesi; M, Fassan; Ferrara, R; M, Genuardi; P, Ghiorzo; S, Gori; F, Guadagni; A, Marchetti; P, Marchetti; M, Midiri; N, Normanno; F, Passiglia; C, Pinto; N, Silvestris; G, Tallini; S, Vatrano; B, Vincenzi; S, Cinieri; G, Beretta | |
| Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors | 1-gen-2021 | Fucà, Giovanni; Galli, Giulia; Poggi, Marta; Lo Russo, Giuseppe; Proto, Claudia; Imbimbo, Martina; Ferrara, R; Zilembo, Nicoletta; Ganzinelli, Monica; Sica, Antonio; Torri, Valter; Colombo Mario, Paolo; Vernieri, Claudio; Balsari, Andrea; de Braud, Filippo; Garassino Marina, Chiara; Signorelli, Diego | |
| Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study | 1-gen-2018 | Lai W., Victoria; Lebas, Louisiane; Barnes Tristan, A.; Milia, Julie; Ni, Ai; Gautschi, Oliver; Peters, Solange; Ferrara, R; Plodkowski Andrew, J.; Kavanagh, John; Sabari Joshua, K.; Clarke Stephen, J.; Pavlakis, Nick; Drilon, Alexander; Rudin Charles, M.; Arcila Maria, E.; Leighl Natasha, B.; Shepherd Frances, A.; Kris Mark, G.; Mazières, Julien; Li Bob, T. | |
| Pseudoprogression in Non-Small Cell Lung Cancer upon Immunotherapy: Few Drops in the Ocean? | 1-gen-2019 | Ferrara, R; Caramella, Caroline; Besse, Benjamin; Champiat, Stéphane | |
| A Case of William's Syndrome in a Ugandan Child: A Feasible Diagnosis Even in a Low-Resource Setting | 1-gen-2021 | Mapelli, Massimo; Zagni, Paola; Calbi, Valeria; Twalib, Aliku; Ferrara, R; Agostoni, Piergiuseppe | |
| Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy | 1-gen-2021 | Ferrara, R; Naigeon, Marie; Auclin, Edouard; Duchemann, Boris; Cassard, Lydie; Jouniaux, Jean-Mehdi; Boselli, Lisa; Grivel, Jonathan; Desnoyer, Aude; Mezquita, Laura; Texier, Matthieu; Caramella, Caroline; Hendriks, Lizza; Planchard, David; Remon, Jordi; Sangaletti, Sabina; Proto, Claudia; Garassino Marina, C.; Soria, Jean-Charles; Marabelle, Aurelien; Voisin, Anne-Laure; Farhane, Siham; Besse, Benjamin; Chaput, Nathalie | |
| Facing the First-line in Metastatic Non-small-cell Lung Cancer – Immunotherapy and Chemotherapy | 1-gen-2020 | De Toma, Alessandro; Lo Russo, Giuseppe; Signorelli, Diego; Ferrara, R; Prelaj, Arsela; Galli, Giulia; Viscardi, Giuseppe; Trevian, Benedetta; Ganzinelli, Monica; Zilembo, Nicoletta; de Braud, Filippo; Garassino, Marina; Proto, Claudia | |
| Hyperprogression and Immune Checkpoint Inhibitors: Hype or Progress? | 1-gen-2020 | Adashek Jacob, J.; Kato, Shumei; Ferrara, R; Lo Russo, Giuseppe; Kurzrock, Razelle | |
| Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors | 1-gen-2019 | Hendriks Lizza, E. L.; Bootsma, Gerben; Mourlanette, Jean; Henon, Clemence; Mezquita, Laura; Ferrara, R; Audigier-Valette, Clarisse; Mazieres, Julien; Lefebvre, Corentin; Duchemann, Boris; Cousin, Sophie; le Pechoux, Cecile; Botticella, Angela; De Ruysscher, Dirk; Dingemans Anne-Marie, C.; Besse, Benjamin | |
| Prognostic value of histogram analysis in advanced non-small cell lung cancer: a radiomic study | 1-gen-2018 | Virginia Bluthgen, Maria; Laura, Faivre; Silvia, Rosellini; Ferrara, R; Francesco, Facchinetti; Eva, Haspinger; Charles, Ferte; Samy, Ammari; Stefan, Michiels; Jean-Charles, Soria; Caroline, Caramella; Benjamin, Besse |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1052
Data di pubblicazione
- In corso di stampa1
- 2020 - 2025644
- 2010 - 2019335
- 2000 - 200940
- 1990 - 199928
- 1985 - 19894
Editore
- MDPI43
- Elsevier B.V.31
- Frontiers Media S.A.30
- MDPI AG30
- Springer26
- Elsevier Inc.21
- Springer Science and Business Med...21
- W.B. Saunders21
- Elsevier Ltd20
- Lippincott Williams and Wilkins18
Rivista
- CANCERS22
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...21
- JOURNAL OF CARDIOTHORACIC AND VAS...15
- OTORINOLARINGOLOGIA13
- CANCER TREATMENT REVIEWS11
- FRONTIERS IN IMMUNOLOGY11
- CRITICAL REVIEWS IN ONCOLOGY HEMA...10
- INTERNATIONAL JOURNAL OF MOLECULA...9
- JOURNAL OF THORACIC ONCOLOGY9
- ACTA OTORHINOLARYNGOLOGICA ITALICA8
Keyword
- Humans184
- Animals50
- Male35
- COVID-1932
- Female25
- Treatment Outcome23
- SARS-CoV-220
- Adult18
- Biomarkers15
- Transplantation14
Lingua
- eng981
- ita52
- fre2
- spa1
Accesso al fulltext
- no fulltext828
- reserved136
- open87
- partially open1